Related Experiment Video
Updated: Feb 10, 2026

08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
5.7K
Translational informatics in personalized medicine.
1US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA. eperakslis@gmail.com.
Personalized Medicine
|May 23, 2018
Summary
Personalized medicine relies on integrating vast biological data. Informatics can advance its use by focusing on multimodal biomarkers and data sharing for better medical outcomes.
Area of Science:
- Genomic Medicine
- Translational Informatics
- Biomarker Discovery
Background:
- Personalized medicine is linked to human genome project advances.
- Deep sequencing and analytical technologies have increased biological data availability.
- Integrating biological data into medically useful knowledge via informatics is challenging.
Purpose of the Study:
- To highlight informatics' role in advancing personalized medicine.
- To identify key areas for informatics to drive progress.
- To emphasize the need for multimodal data integration.
Main Methods:
- Analysis of current trends in personalized medicine and informatics.
- Review of opportunities in multimodal biomarker exploitation.
- Discussion on the importance of precompetitive data sharing.
- Emphasis on balancing high-content and phenotypic data.
Main Results:
- Translational informatics is crucial for realizing personalized medicine's potential.
- Exploiting multimodal biomarkers offers significant opportunities.
- Precompetitive data sharing is essential for progress.
- Integrating high-content and rich phenotypic data is key.
Conclusions:
- Informatics is pivotal for the widespread adoption of personalized medicine.
- Focusing on multimodal biomarkers and data sharing will accelerate progress.
- A balanced approach to data integration is necessary for clinical utility.
Related Concept Videos
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Translation
157.2K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.2K
Translation
17.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.9K
Initiation of Translation
39.2K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.2K
Termination of Translation
27.8K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.8K
Termination of Translation
6.8K
6.8K

